How can the OMNIgene®•GUT Dx device revolutionize clinical microbiome research?

In our latest panel discussion, Standardizing stool sampling: Value of FDA authorization, we disseminate the device’s journey in receiving FDA authorization and why this designation is important for diagnostic and therapeutic assay developers.

Hear from our team of experts from Regulatory Affairs, Product Management and Research & Development on:

Why FDA authorization designation is important for the diagnostic and therapeutic industry
The clinical applications that could benefit from the OMNIgene•GUT Dx device
Reasons why you can trust this device for your clinical research needs

Collect superior samples for your microbiome analysis, increase donor compliance and improve efficiency through reduced validation time and proven reproducibility with the OMNIgene• GUT Dx device.

Share your details to view complete panel discussion

First Name *

Last Name *

Email *

Phone *

Institute/Company *

How do you describe your market segment *

Job Title *

Country *

Comments

By submitting your details, you are consenting to receive e-mail communication.